Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    beta 2-Microglobulin/FCGRT Antibody (101), PE, Novus Biologicals™
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP312815PE
Description
beta 2-Microglobulin/FCGRT Monoclonal antibody specifically detects beta 2-Microglobulin/FCGRT in Human samples. It is validated for ELISASpecifications
| beta 2-Microglobulin/FCGRT | |
| Monoclonal | |
| PE | |
| PBS | |
| Rabbit | |
| Protein A purified | |
| RUO | |
| 567 | |
| Store at 4C in the dark. | |
| IgG | 
| ELISA | |
| 101 | |
| ELISA | |
| alpha-chain, beta chain of MHC class I molecules, beta-2-microglobin, beta-2-microglobulin, Fc fragment of IgG, receptor, transporter, alpha, FcRn, FcRn alpha chain, heavy chain of the major histocompatibility complex class I-like Fc receptor, IgG Fc fragment receptor transporter alpha chain, IgG receptor FcRn large subunit p51, IMD43, immunoglobulin receptor, intestinal, heavy chain, major histocompatibility complex class I-like Fc receptor, Neonatal Fc receptor, neonatal Fc-receptor for Ig, transmembrane alpha chain of the neonatal receptor | |
| This antibody was obtained from a rabbit immunized with purified, recombinant Human beta 2-Microglobulin/FCGRT (Uniprot#: P55899-1 and P61770-1; Met1-Ser297 and Met1-Met119). | |
| 0.1 mL | |
| Primary | |
| Human | |
| Purified | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            